Further pathway enrichment and network analyses revealed a substantial effect of Cyp17a1 genotype on associated cardiovascular and obesity-related pathways involving aspartate and L-arginine. This evidence concerns the gene CYP17A1 and obesity due to melanocortin 4 receptor deficiency.